The Systemic Inflammatory Response and Its Relationship to Pain and Other Symptoms in Advanced Cancer

Abstract

Introduction. Inflammation has been identified as a hallmark of cancer and may be necessary for tumorgenesis and maintenance of the cancer state. Inflammation‐related symptoms are common in those with cancer; however, little is known about the relationship between symptoms and systemic inflammation in cancer. The aim of the present study was to examine the relationship between symptoms and systemic inflammation in a large cohort of patients with advanced cancer. Methods. Data from an international cohort of patients with advanced cancer were analyzed. Symptoms and patient‐related outcomes were recorded using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire—Core Questionnaire. Systemic inflammation was assessed using C‐reactive protein levels. The relationship between these symptoms and systemic inflammation was examined using Spearman rank correlation (ρ) and the Mann‐Whitney U test. Results. Data were available for 1,466 patients across eight European countries; 1,215 patients (83%) had metastatic disease at study entry. The median survival was 3.8 months (interquartile range [IQR] 1.3–12.2 months). The following were associated with increased levels of inflammation: performance status (ρ = .179), survival (ρ = .347), pain (ρ = .154), anorexia (ρ = .206), cognitive dysfunction (ρ = .137), dyspnea (p= .150), fatigue (ρ = .197), physical dysfunction (ρ = .207), role dysfunction (ρ = .176), social dysfunction (ρ = .132), and poor quality of life (ρ = .178). All were statistically significant at p < .001. Conclusion. The results show that the majority of cancer symptoms are associated with inflammation. The strength of the potential relationship between systemic inflammation and common cancer symptoms should be examined further within the context of an anti‐inflammatory intervention trial.

Symptom Clusters in Advanced Cancer Patients: An Empirical Comparison of Statistical Methods and the Impact on Quality of Life

“…In addition, the fatigue-pain cluster strongly predicted health and all three aspects of functioning for every cancer site, consistent with previous research (32)(33)(34)(35). We found weak associations between depression and fatigue-pain across cancers, despite previous findings that fatigue-pain-depression were associated with reduced physical function and co-occurred in clinical practice (33). Furthermore, previous studies suggest links between emotional symptoms, fatigue and pain, specifically:…”

Salivary diurnal cortisol profiles in patients suffering from chronic breathlessness receiving supportive and palliative care services: A cross-sectional study

“…This process has been identified in many chronic diseases commonly associated with breathlessness, such as COPD (Gan et al, 2004) and cancer (Laird et al, 2013). In these contexts, it may contribute to disability due to breathlessness (MRC dyspnoea grade) by inducing skeletal muscle atrophy (Cohen et al, 2015).…”

Updates in palliative care – overview and recent advancements in the pharmacological management of cancer pain

“…27 Furthermore, the relationship between opioid use and shorter survival may be due to more aggressive disease being more painful, necessitating opioid use; the primary association might be between the more aggressive disease and shorter survival. 29,30 Pain might also affect survival, so based on currently available data opioids should continue to be used.…”